Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study-Reference-Cited by-同舟云学术

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study

Published:2023-05 Issue:5 Volume:8 Page:968-979
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Rizk Dana V.,Rovin Brad H.^ORCID,Zhang Hong,Kashihara Naoki,Maes Bart,Trimarchi Hernán^ORCID,Perkovic Vlado,Meier Matthias,Kollins Dmitrij,Papachristofi Olympia,Charney Alan,Barratt Jonathan

Funder

Novartis

Novartis Pharma AG

Publisher

Elsevier BV

Subject

Nephrology

Reference41 articles.

1. IgA nephropathy;Wyatt;N Engl J Med,2013

2. IgA nephropathy;Lai;Nat Rev Dis Primers,2016

3. Natural history of primary IgA nephropathy;Berthoux;Semin Nephrol,2008

4. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population;Le;Nephrol Dial Transplant,2012

5. IgA nephropathy;Rodrigues;Clin J Am Soc Nephrol,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathogenesis of IgA nephropathy and implications for treatment;Nature Reviews Nephrology;2024-09-04

2. Long-term renal survival in patients with IgA nephropathy: a systematic review;Renal Failure;2024-08-27

3. First Successful Treatment of a Patient with a Primary Immune Complex-Membranoproliferative Glomerulonephritis with Iptacopan: A Case Report;Case Reports in Nephrology and Dialysis;2024-08-07

4. State-of-Art Therapeutics in IgA Nephropathy;Indian Journal of Nephrology;2024-06-24

5. Iptacopan: First Approval;Drugs;2024-03-22